JRX is a skin delivery system and specialty biochemistry technology company. We are focused on developing and commercializing our DermX^TM MegasphereTM Delivery System - a novel and patented transdermal delivery system technology platform that has been independently proven to allow high molecular weight molecules to penetrate deep into human skin.

The company's DermX^TM MegasphereTM Delivery System has been proven three times over:

1. In the lab – in vitro; using Franz Cell testing methodologies,
2. In the clinic – in vivo; anti-aging products tested at a independent skin care testing
       facility, and
3. In the market – sales of Hydroderm, an anti-wrinkle product that has generated well
       over $100 million in retail sales to date.

JRX Biotech is looking to expand its technology partnership reach throughout the personal care, cosmetics, Over-the-Counter (OTC), and prescription (Rx) industries.